My Portfolio
+
LINK YOUR PORTFOLIO

Regenxbio Inc RGNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:08 PM EDT
6.60quote price arrow down-0.09 (-1.35%)
Volume
10,514
Close
6.69quote price arrow up+0.17 (+2.61%)
Volume
1,258,575
52 week range
5.46 - 16.19
Loading...
  • Open6.73
  • Day High6.78
  • Day Low6.52
  • Prev Close6.52
  • 52 Week High16.19
  • 52 Week High Date01/22/26
  • 52 Week Low5.46
  • 52 Week Low Date05/18/26

Key Stats

  • Market Cap345.857M
  • Shares Out51.70M
  • 10 Day Average Volume1.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.02

KEY STATS

  • Open6.73
  • Day High6.78
  • Day Low6.52
  • Prev Close6.52
  • 52 Week High16.19
  • 52 Week High Date01/22/26
  • 52 Week Low5.46
  • 52 Week Low Date05/18/26
  • Market Cap345.857M
  • Shares Out51.70M
  • 10 Day Average Volume1.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.02

RATIOS/PROFITABILITY

  • EPS (TTM)-5.59
  • P/E (TTM)-1.20
  • Fwd P/E (NTM)-2.55
  • EBITDA (TTM)-241.17M
  • ROE (TTM)-196.43%
  • Revenue (TTM)87.822M
  • Gross Margin (TTM)68.19%
  • Net Margin (TTM)-330.23%
  • Debt To Equity (MRQ)841.14%

EVENTS

  • Earnings Date08/05/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address an array of diseases. It is focused on its internal development pipeline in three areas: retinal, neuromuscular, and neurodegenerative diseases. Its investigational AAV...
Kenneth Mills
Chairman of the Board
Curran Simpson
President, Chief Executive Officer, Director
Mitchell Chan
Chief Financial Officer, Executive Vice President, Treasurer
Patrick Christmas II
Executive Vice President, Chief Strategy and Legal Officer
Craig Malzahn
Executive Vice President - Product Development, Chief Technology Officer
Address
9804 Medical Center Drive
Rockville, MD
20850
United States